- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top U.S. states by financial penalties for pharmaceutical companies 1991-2015
Top U.S. states by financial penalties for pharmaceutical companies 1991-2015
Top U.S. states based on financial penalties for pharmaceutical companies between 1991 and 2015 (in million U.S. dollars)*
This statistic represents top US states based on financial penalties for pharmaceutical companies between 1991 and 2015. In that period, Louisiana claimed some 300 million U.S. dollars through penalties from pharmaceutical companies.
Top U.S. states based on financial penalties for pharmaceutical companies between 1991 and 2015 (in million U.S. dollars)*
Loading statistic...
| Penalties in million U.S. dollars | |
|---|---|
| Texas | 690.1 |
| Louisiana | 300.6 |
| California | 210.3 |
| Pennsylvania | 189.9 |
| South Carolina | 169 |
| Kentucky | 147.3 |
| Alabama | 124.3 |
| Mississippi | 106.5 |
| Hawaii | 83.8 |
| Florida | 75.8 |
| Penalties in million U.S. dollars | |
|---|---|
| Texas | 690.1 |
| Louisiana | 300.6 |
| California | 210.3 |
| Pennsylvania | 189.9 |
| South Carolina | 169 |
| Kentucky | 147.3 |
| Alabama | 124.3 |
| Mississippi | 106.5 |
| Hawaii | 83.8 |
| Florida | 75.8 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic represents top US states based on financial penalties for pharmaceutical companies between 1991 and 2015. In that period, Louisiana claimed some 300 million U.S. dollars through penalties from pharmaceutical companies.
Show more- Show sources information
- Show publisher information
- Release date
- March 2016
- Region
- United States
- Survey time period
- 1991 to 2015
- Supplementary notes
- * From single-state and multi-state settlements between state governments and pharmaceutical manufacturers.
Source
- Show sources information
- Show publisher information
- Release date
- March 2016
More information
- Region
- United States
- Survey time period
- 1991 to 2015
- Supplementary notes
- * From single-state and multi-state settlements between state governments and pharmaceutical manufacturers.
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)Research and development in European pharmaceutical industry by country 2016
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2003 and 2017Yearly growth rate of R&D spending in pharmaceutical industry 2003-2017
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2015
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)Leading European pharmaceutical & biotechnology companies ranked by market value 2015
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)Leading European pharmaceutical companies by R&D spending 2015
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)Leading European pharmaceutical companies by R&D investment 2014
- Pharmaceutical production value of EFPIA members from 1990 to 2017 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2017
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2017 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2017
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2016Employment in European pharmaceutical industry by country 2016
- Total pharmaceutical employment in EFPIA countries from 1990 to 2017Employment in EFPIA pharmaceutical industry 1990-2017
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2017Italy: number of employees in the pharmaceutical industry 2000-2017
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Pharmaceutical industry settlements number - state and federal governments 1991-2015
- Top pharmaceutical companies in Canada by market share 2016
- Italy: foreign invested enterprises in the pharmaceutical sector 2009-2015
- Italy: enterprises in the pharamceutical sector November 2017, by branch
- Italy: turnover of foreign invested enterprises of pharmaceuticals 2009-2015
- Italy: perception of pharmaceutical companies 2018, by brand
- Italy: tangible investments of leading pharmaceutical companies 2009-2016
- Italy: international turnover of leading pharmaceutical companies 2007-2017
- Italy: workforce of leading pharmaceutical companies 2014-2016, by department
- US adults who believe current economic situation has influence on US pharma industry
- Top pharmaceutical companies in Argentina 2014 by revenue
- Italy: workforce of leading pharmaceutical companies 2007-2017
- US adults who believe current economic players have influence on US pharma industry
- Revenue of the top ten pharmaceutical companies in France 2016
- US adults who believe politics have an influence the US pharma industry
- Total number of pharmaceutical merger and acquisition deals 2004-2014
- Leading European pharmaceutical companies by R&D spending 2017
- Total value of pharmaceutical merger and acquisition deals 2004-2014
- DTC media spending of rheumatology products U.S. 2013
- Leading Japanese pharmaceutical companies 2014, by revenue
Studies
- Pharmaceutical industry in Italy
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Pharmaceutical industry in the Netherlands
- Vaccine industry in China
- Pharmaceutical trends in Europe
- Indicatori Farmaceutici
- 2018 PhRMA Annual Membership Survey
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- Generic Pharmaceutical Industry Yearbook 2016
- Biotechnology in Germany
- Biotechnology Industry in Europe
- Unleashing Pharma from the R&D Value Chain
- Diagnóstico Sectorial Farmacéutico
- 2015 Global life sciences outlook
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*
- Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2003 and 2017
- Market share of generics in selected European countries as of 2016
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2017 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2017 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2016
- Total pharmaceutical employment in EFPIA countries from 1990 to 2017
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2017
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Number of pharmaceutical industry settlements with U.S. state and federal governments from 1991 to 2015
- Top 10 pharmaceutical companies in Canada in 2016, by market share
- Number of foreign invested enterprises in the pharmaceutical sector in Italy from 2009 to 2015
- Number of enterprises in the pharmaceutical sector in Italy as of November 2017, by branch
- Turnover of foreign invested enterprises in the pharmaceutical sector in Italy from 2009 to 2015 (in million euros)
- Perceived reputation of pharmaceutical companies among Italians in 2018, by brand*
- Aggregated value of tangible investments made by Italian leading pharmaceutical companies from 2009 to 2016 (in million euros)
- Share of turnover generated abroad by the leading Italian pharmaceutical companies from 2007 to 2017
- Distribution of employees of Italian leading pharmaceutical companies from 2014 to 2016, by department
- In your opinion, how big is the influence of the economic situation on the U.S. pharma industry?
- Leading pharmaceutical companies in Argentina between October 2013 and October 2014, by revenue (in million U.S. dollars)
- Worldwide aggregated number of employees of Italian leading pharmaceutical companies from 2007 to 2017
- In your opinion, how big is the influence of current economic players on the U.S. pharma industry?
- Ranking of the top ten pharmaceutical companies in France in 2016, according to turnover (in euros)
- In your opinion, how big is the influence of politics on the U.S. pharma industry?
- Number of pharmaceutical merger and acquisition deals worldwide from 2004 to 2014
- Leading European pharmaceutical companies by spending on research and development in 2017 (in billion U.S. dollars)
- Value of pharmaceutical merger and acquisition deals worldwide from 2004 to 2014 (in billion U.S. dollars)
- Direct to consumer media spending of selected rheumatology products in the United States in 2013 (in million U.S. dollars)
- Leading Japanese pharmaceutical companies in 2014, by revenue (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.